MAP3K14 and breast carcinoma: Another study indicated that the positive expression rate of NIK in breast carcinoma tissue was significantly higher than that in normal tissue by immunohistochemistry and the 5-year survival of breast cancer patients with positive NIK expression was significantly lower than in those with negative NIK expression (24).